We already have products that contain less than 0.3% THC. We could offer that type of product to Canadians, but the intensity of pain and suffering varies greatly, and a product containing less than 0.3% THC would not be enough to provide relief to some patients. So the reach of that exemption is going to be limited.
On May 9th, 2018. See this statement in context.